Canada Backs Aspect Biosystems With $280M to Scale Bioprinted Tissue Therapies

The Government of Canada is supporting bioprinting company Aspect Biosystems with a new $280 million project to help develop and manufacture its bioengineered cellular medicines. The project will run over...